Submissions from 2014
Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial, W. W. Fleischhacker, J. M. Kane, J. Geier, O. Karayal, S. Kolluri, S. M. Eng, R. F. Reynolds, and B. L. Strom
Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study, W. W. Fleischhacker, R. Sanchez, T. Peters-Strickland, B. R. Johnson, R. A. Baker, A. Eramo, R. D. McQuade, W. H. Carson, D. Walling, J. M. Kane, and +2 additional authors
Bone Morphogenetic Protein-focused Strategies to Induce Cytotoxicity in Lung Cancer Cells, A. Fotinos, N. Nagarajan, A. S. Martins, D. T. Fritz, D. Garsetti, A. T. Lee, C. C. Hong, and M. B. Rogers
Lloyd Mayer, MD, 1952-2013, In Memoriam, S. M. Fu, C. Cunningham-Rundles, B. Diamond, D. Rotrosen, W. Stohl, and C. Terhorst
Circulating complexes of the vitamin D binding protein with G-actin induce lung inflammation by targeting endothelial cells, L. Y. Ge, G. Trujillo, E. J. Miller, and R. R. Kew
National Trends in Second-Generation Antipsychotic Augmentation for Nonpsychotic Depression, T. Gerhard, A. Akincigil, C. U. Correll, N. J. Foglio, S. Crystal, and M. Olfson
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles, J. I. Goldstein, L. F. Jarskog, C. Hilliard, A. Alfirevic, H. L. Huang, M. Lek, A. L. Holden, D. L. Kelly, A. K. Malhotra, P. F. Sullivan, and +21 additional authors
Frequency of Involuntary Admissions and Its Associations With Demographic and Clinical Characteristics in China, L. Gou, J. S. Zhou, Y. T. Xiang, X. M. Zhu, C. U. Correll, G. S. Ungvari, H. F. K. Chiu, K. Y. C. Lai, and X. P. Wang
Immunochip Identifies Novel, and Replicates Known, Genetic Risk Loci for Rheumatoid Arthritis in Black South Africans, N. Govind, A. Choudhury, B. Hodkinson, C. Ickinger, J. Frost, A. Lee, P. K. Gregersen, R. J. Reynolds, S. L. Bridges, M. Tikly, and +2 additional authors
Genetics. A genomic road map for complex human disease, P. K. Gregersen
The Power of a Modular Approach to Transcriptional Analysis, P. K. Gregersen and M. Oswald
Suicidality and hospitalization as cause and outcome of pediatric psychiatric emergency room visits, E. Grudnikoff, E. C. Soto, A. Frederickson, M. L. Birnbaum, E. Saito, R. Dicker, J. M. Kane, and C. U. Correll
Characteristics and disposition of youth referred from schools for emergency psychiatric evaluation, E. Grudnikoff, T. Taneli, and C. U. Correll
The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches, S. Gupta, J. D. Cahill, M. Ranganathan, and C. U. Correll
Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity, B. Han, D. Diogo, S. Eyre, H. Kallberg, A. Zhernakova, J. Bowes, L. Padyukov, Y. Okada, P. K. Gregersen, S. Raychaudhuri, and +8 additional authors
Sudden unexpected death in schizophrenia: Autopsy findings in psychiatric inpatients, P. Ifteni, C. U. Correll, V. Burtea, J. M. Kane, and P. Manu
Rapid clozapine titration in treatment-refractory bipolar disorder, P. Ifteni, C. U. Correll, J. Nielsen, V. Burtea, J. M. Kane, and P. Manu
Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report, P. Ifteni, M. A. Moga, V. Burtea, and C. U. Correll
Effectiveness and safety of rapid clozapine titration in schizophrenia, P. Ifteni, J. Nielsen, V. Burtea, C. U. Correll, J. M. Kane, and P. Manu
Lenalidomide and Rituximab for the Initial Treatment of Patients With Chronic Lymphocytic Leukemia: A Multicenter Clinical-Translational Study From the Chronic Lymphocytic Leukemia Research Consortium, D. F. James, L. Werner, J. R. Brown, W. G. Wierda, J. C. Barrientos, J. E. Castro, A. Greaves, A. J. Johnson, K. R. Rai, T. J. Kipps, and +2 additional authors
Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies, M. Jani, J. Massey, L. R. Wedderburn, J. Vencovsky, K. Danko, I. E. Lundberg, L. Padyukov, A. Lee, P. K. Gregersen, Eumyonet, and +10 additional authors
Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis, H. Ji, M. F. Rabbi, B. Labis, V. A. Pavlov, K. J. Tracey, and J. E. Ghia
Clinical and cost implications of treating schizophrenia: safety, efficacy, relapse prevention, and patient outcomes, J. M. Kane, C. U. Correll, P. D. Harvey, and M. Olfson
Financial incentives improve adherence to maintenance antipsychotic treatment, John Kane
Technology-based interventions in health care, John Kane
Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study, John Kane, T. Peters-Strickland, R. A. Baker, P. Hertel, A. Eramo, N. Jin, P. P. Perry, M. Gara, R. D. McQuade, R. Sanchez, and +1 additional author
Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis, John Kane, C. Zhao, B. R. Johnson, R. A. Baker, A. Eramo, R. D. McQuade, A. R. Duca, R. Sanchez, and T. Peters-Strickland
Brief Pulse and Ultrabrief Pulse Right Unilateral Electroconvulsive Therapy (ECT) for Major Depression: Efficacy, Effectiveness, and Cognitive Effects, C. H. Kellner, S. M. McClintock, W. V. McCall, G. Petrides, R. G. Knapp, R. D. Weiner, R. C. Young, R. M. Greenberg, M. V. Rudorfer, S. H. Lisanby, and +2 additional authors
Modulation of tolerogenic dendritic cells and autoimmunity, S. J. Kim and B. Diamond
The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males, E. Koiliari, P. Roussos, E. Pasparakis, T. Lencz, Anil Malhotra, L. J. Siever, S. G. Giakoumaki, and P. Bitsios
Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients, E. Kozora, D. Erkan, L. Zhang, R. Zimmerman, G. Ramon, A. M. Ulug, and M. D. Lockshin
Robotic Measurement of Arm Movements After Stroke Establishes Biomarkers of Motor Recovery, H. I. Krebs, M. Krams, D. K. Agrafiotis, A. DiBernardo, J. C. Chavez, G. S. Littman, E. Yang, G. Byttebier, L. Dipietro, B. T. Volpe, and +4 additional authors
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States, A. Kwan, R. S. Abraham, R. Currier, A. Brower, K. Andruszewski, J. K. Abbott, M. Baker, M. Ballow, L. E. Bartoshesky, V. R. Bonagura, and +70 additional authors
Genome-Wide Methylation Analyses in Glioblastoma Multiforme, R. K. Lai, Y. W. Chen, X. W. Guan, D. Nousome, C. Sharma, P. Canoll, J. Bruce, A. Lee, P. Gregersen, J. Barnholtz-Sloan, and +8 additional authors
Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial, J. R. Larsen, L. Vedtofte, J. J. Holst, P. Oturai, A. Kjaer, Christoph Correll, T. Vilsboll, and A. Fink-Jensen
Symptomatic and functional remission of subjects at clinical high risk for psychosis: A 2-year naturalistic observational study, T. Y. Lee, S. N. Kim, Christoph Correll, M. S. Byun, E. Kim, J. H. Jang, D. H. Kang, J. Y. Yun, and J. S. Kwon
Characteristics, symptomatology and naturalistic treatment in individuals at-risk for bipolar disorders: Baseline results in the first 180 help-seeking individuals assessed at the dresden high-risk project, K. Leopold, S. Ratzer, Christoph Correll, M. Rottmann-Wolf, S. Pfeiffer, P. Ritter, M. Bauer, and A. Pfennig
Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury, J. K. Lerch, D. A. Puga, O. Bloom, and P. G. Popovich
25-Hydroxyvitamin D and Cardiovascular Disease in Patients With Systemic Lupus Erythematosus: Data From a Large International Inception Cohort, A. Lertratanakul, P. Wu, A. Dyer, M. Urowitz, D. Gladman, C. Aranow, J. Font, R. van Vollenhoven, T. Stoll, R. Ramsey-Goldman, and +20 additional authors
Erratum to: Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial (vol 157, pg 112, 2014), H. F. Li, J. F. Luo, C. Y. Wang, S. P. Xie, X. F. Xu, X. P. Wang, W. J. Yu, N. F. Gu, and J. M. Kane
Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial, H. F. Li, J. F. Luo, C. Y. Wang, S. P. Xie, X. F. Xu, X. P. Wang, W. J. Yu, N. F. Gu, and John Kane
Implications of Gender Difference in Coronary Calcification as Assessed by CT Coronary Angiography, A. N. Makaryus, C. Sison, M. Kohansieh, and J. N. Makaryus
Genes and Schizophrenia: From a Festschrift Seminar Honoring William T. Carpenter Jr, MD, Anil Malhotra
Markers of inflammation in schizophrenia: association vs. causation, P. Manu, C. U. Correll, M. Wampers, A. J. Mitchell, M. Probst, D. Vancampfort, and M. De Hert
The content of attenuated psychotic symptoms in those at clinical high risk for psychosis, C. Marshall, E. Denny, K. S. Cadenhead, T. D. Cannon, Barbara Cornblatt, T. H. McGlashan, D. O. Perkins, L. J. Seidman, M. T. Tsuang, J. Addington, and +2 additional authors
A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen, G. Matteoli, P. J. Gomez-Pinilla, A. Nemethova, M. Di Giovangiulio, C. Cailotto, S. H. van Bree, K. Michel, K. J. Tracey, P. Vanden Berghe, G. E. Boeckxstaens, and +2 additional authors
Could the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) be used in depressed schizophrenia patients?, X. R. Ma, C. L. Hou, Y. Zang, F. J. Jia, Y. Q. Lin, Y. Li, H. F. Chiu, G. S. Ungvari, Christoph Correll, Y. T. Xiang, and +5 additional authors
Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis, M. D. Mayes, L. Bossini-Castillo, O. Gorlova, J. E. Martin, X. D. Zhou, W. V. Chen, S. Assassi, P. K. Gregersen, A. T. Lee, J. Martin, and +66 additional authors
Predicting and preventing bipolar disorder: the need to fundamentally advance the strategic approach, R. S. McIntyre and Christoph Correll
The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study, E. C. Meyer, Ricardo Carrion, Barbara Cornblatt, J. Addington, K. S. Cadenhead, T. D. Cannon, T. H. McGlashan, D. O. Perkins, M. T. Tsuang, L. J. Seidman, and +3 additional authors
MHC associations with clinical and autoantibody manifestations in European SLE, D. L. Morris, M. M. A. Fernando, K. E. Taylor, S. A. Chung, J. Nititham, M. E. Alarcon-Riquelme, L. F. Barcelloss, T. W. Behrens, P. K. Gregersen, Con Syst Lupus Erythematosus Genet, and +13 additional authors
Central Muscarinic Cholinergic Activation Alters Interaction between Splenic Dendritic Cell and CD4(+)CD25(-) T Cells in Experimental Colitis, P. Munyaka, M. F. Rabbi, V. A. Pavlov, K. J. Tracey, E. Khafipour, and J. E. Ghia
Disease-Free Survival According to the Use of Postmastectomy Radiation Therapy After Neoadjuvant Chemotherapy, H. Nagar, D. Boothe, P. S. Ginter, C. Sison, L. Vahdat, S. Shin, M. Smith, K. S. Chao, D. Nori, and M. K. Hayes
Is There a Tradeoff in Using Modified High Tangent Field Radiation for Treating an Undissected Node-Positive Axilla?, H. Nagar, L. L. Zhou, B. Biritz, C. Sison, J. H. Chang, M. Smith, D. Nori, K. S. C. Chao, and M. K. Hayes
Comment on 'effectiveness and safety of rapid clozapine titration in schizophrenia' Reply, J. Nielsen, P. Ifteni, P. Manu, J. Kane, and C. Correll
Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study, J. Nielsen, S. O. Jensen, R. B. Friis, J. B. Valentin, and Christoph Correll
Risk of Diabetes in Children and Adolescents Exposed to Antipsychotics: A Nationwide 12-Year Case-Control Study, R. E. Nielsen, M. F. Laursen, D. L. Vernal, C. Bisgaard, H. Jakobsen, H. C. Steinhausen, and Christoph Correll
The relationship between temperament and character and subclinical psychotic-like experiences in healthy adults, G. C. Nitzburg, Anil Malhotra, and P. DeRosse
Integration of Sequence Data from a Consanguineous Family with Genetic Data from an Outbred Population Identifies PLB1 as a Candidate Rheumatoid Arthritis Risk Gene, Y. Okada, D. Diogo, J. D. Greenberg, F. Mouassess, W. A. L. Achkar, R. S. Fulton, J. C. Denny, N. Gupta, P. K. Gregersen, R. M. Plenge, and +38 additional authors
Fine Mapping Major Histocompatibility Complex Associations in Psoriasis and Its Clinical Subtypes, Y. Okada, B. Han, L. C. Tsoi, P. E. Stuart, E. Ellinghaus, T. Tejasvi, V. Chandran, F. Pellett, P. K. Gregersen, S. Raychaudhuri, and +12 additional authors
Genetics of rheumatoid arthritis contributes to biology and drug discovery, Y. Okada, D. Wu, G. Trynka, T. Raj, C. Terao, K. Ikari, Y. Kochi, K. Ohmura, P. K. Gregersen, R. M. Plenge, and +85 additional authors
National Trends in the Mental Health Care of Children, Adolescents, and Adults by Office-Based Physicians, M. Olfson, C. Blanco, S. Wang, G. Laje, and Christoph Correll
No Causal Association Between Electroconvulsive Therapy and Death A Summary of a Report From the Danish Health and Medicines Authority Covering 99,728 Treatments, S. D. Ostergaard, T. G. Bolwig, and G. Petrides
Risk factors for conversion from unipolar psychotic depression to bipolar disorder, S. D. Ostergaard, S. Straszek, G. Petrides, S. Skadhede, S. O. W. Jensen, P. Munk-Jorgensen, and J. Nielsen
Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial, A. K. Pagsberg, P. Jeppesen, D. G. Klauber, K. G. Jensen, D. Ruda, M. Stentebjerg-Olesen, P. Jantzen, S. Rasmussen, Christoph Correll, B. Fagerlund, and +19 additional authors
Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials, A. K. Pagsberg, S. Tarp, D. Glintborg, A. D. Stenstrom, A. Fink-Jensen, Christoph Correll, and R. Christensen
SENTIA: a systematic online monitoring registry for children and adolescents treated with antipsychotics, I. Palanca-Maresca, B. Ruiz-Antoran, G. Centeno-Soto, S. Jimenez-Fernandez, L. Garcia-Murillo, A. Siles, S. Villagra, H. Blasco-Fontecilla, L. Iruela-Cuadrado, Christoph Correll, and +2 additional authors
Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project, D. O. Perkins, C. D. Jeffries, J. Addington, C. E. Bearden, K. S. Cadenhead, T. D. Cannon, Barbara Cornblatt, D. H. Mathalon, S. W. Woods, R. Heinssen, and +4 additional authors
Psychotherapeutic interventions in individuals at risk of developing bipolar disorder: a systematic review, A. Pfennig, C. U. Correll, C. Marx, M. Rottmann-Wolf, T. D. Meyer, M. Bauer, and K. Leopold
Early specific cognitive-behavioural psychotherapy in subjects at high risk for bipolar disorders: study protocol for a randomised controlled trial, A. Pfennig, K. Leopold, A. Bechdolf, C. U. Correll, M. Holtmann, M. Lambert, C. Marx, T. D. Meyer, G. Juckel, M. Bauer, and +5 additional authors
Adherence to Guidelines for Glucose Assessment in Starting Second-Generation Antipsychotics, M. A. Raebel, R. Penfold, A. W. McMahon, M. Reichman, S. Shetterly, G. Goodrich, S. Andrade, C. U. Correll, and T. Gerhard
Movement toward Optimization of CLL Therapy, K. R. Rai and J. C. Barrientos
HLA-DRB1-Associated Rheumatoid Arthritis Risk at Multiple Levels in African Americans Hierarchical Classification Systems, Amino Acid Positions, and Residues, R. J. Reynolds, A. F. Ahmed, M. I. Danila, L. B. Hughes, P. K. Gregersen, S. Raychaudhuri, R. M. Plenge, S. L. Bridges, and Af Consortium Longitudinal Evaluat
Biological insights from 108 schizophrenia-associated genetic loci, S. Ripke, B. M. Neale, A. Corvin, J. T. R. Walters, K. H. Farh, T. Lencz, A. K. Malhotra, Consortium Psychiat Genomics, Conso Psychosis Endophenotypes Int, Consor Wellcome Trust Case-Control, and +292 additional authors
Radiation Absorbed Dose to the Basal Ganglia from Dopamine Transporter Radioligand F-18-FPCIT, W. Robeson, V. Dhawan, Y. L. Ma, D. Bjelke, C. Margouleff, T. Chaly, and D. Eidelberg
Child and Adolescent Psychiatrists' Attitudes and Practices Prescribing Second Generation Antipsychotics, A. M. Rodday, S. K. Parsons, C. U. Correll, A. S. Robb, B. T. Zima, T. S. Saunders, and L. K. Leslie
A Role for Noncoding Variation in Schizophrenia, P. Roussos, A. C. Mitchell, G. Voloudakis, J. F. Fullard, V. M. Pothula, J. Tsang, E. A. Stahl, A. Georgakopoulos, P. K. Gregersen, P. Sklar, and +15 additional authors
Perceived discrimination in those at clinical high risk for psychosis, M. M. Saleem, J. Stowkowy, K. S. Cadenhead, T. D. Cannon, B. Cornblatt, T. H. McGlashan, D. O. Perkins, L. J. Seidman, M. T. Tsuang, S. W. Woods, and +2 additional authors
Diabetes risk potentially underestimated in youth and children receiving antipsychotics, K. Samaras, C. U. Correll, A. J. Mitchell, and M. De Hert
Emerging Paradigm of Primary Immunodeficiency Disease: Individualizing Immunoglobulin Dose and Delivery to Enhance Outcomes, R. S. Shapiro, R. L. Wasserman, V. Bonagura, and S. Gupta
A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia, J. H. Q. Shen, Y. G. Zhao, S. Rosenzweig-Lipson, D. Popp, J. B. W. Williams, E. Giller, M. J. Detke, and J. Kane
Bacteria and the Neural Code, B. E. Steinberg, K. J. Tracey, and A. S. Slutsky
Does Adjuvant Radiotherapy Benefit Patients With Diffuse-Type Gastric Cancer? Results From the Surveillance, Epidemiology, and End Results Database, A. M. Stessin, C. Sison, A. Schwartz, J. Ng, C. K. S. Chao, and B. Q. Li
A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia, B. Stubbs, M. De Hert, A. A. Sepehry, C. U. Correll, A. J. Mitchell, A. Soundy, J. Detraux, and D. Vancampfort
The prevalence and moderators of clinical pain in people with schizophrenia: A systematic review and large scale meta-analysis, B. Stubbs, A. J. Mitchell, M. De Hert, C. U. Correll, A. Soundy, M. Stroobants, and D. Vancampfort
Aggression in Schizophrenia and its Relationship to Neural Circuitry of Urgency, P. Szeszko
Self-Reported and Interviewer-Rated Oral Health in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder, L. R. Tang, W. Zheng, H. Zhu, X. Ma, H. F. Chiu, C. U. Correll, G. S. Ungvari, Y. Q. Xiang, K. Y. Lai, X. L. Cao, Y. Li, B. L. Zhong, K. I. Lok, and Y. T. Xiang
Functional development in clinical high risk youth: Prediction of schizophrenia versus other psychotic disorders, S. I. Tarbox, J. Addington, K. S. Cadenhead, T. D. Cannon, B. Cornblatt, D. O. Perkins, L. J. Seidman, M. T. Tsuang, E. F. Walker, S. W. Woods, and +2 additional authors
Lymphocyte called home: beta2-adreneric neurotransmission confines T cells to lymph nodes to suppress inflammation, K J. Tracey
Hypertension: An Immune Disorder?, K. J. Tracey
Approaching the Next Revolution? Evolutionary Integration of Neural and Immune Pathogen Sensing and Response, K. J. Tracey
Molecular medicine commemorates the career and science of anthony cerami, K. J. Tracey
Stress exposure and sensitivity in the clinical high-risk syndrome: Initial findings from the North American Prodrome Longitudinal Study (NAPLS), H. D. Trotman, C. W. Holtzman, E. F. Walker, J. M. Addington, C. E. Bearden, K. S. Cadenhead, T. D. Cannon, B. Cornblatt, R. K. Heinssen, T. H. McGlashan, and +5 additional authors
Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program, I. F. Tso, S. F. Taylor, T. B. Grove, T. Niendam, S. Adelsheim, A. Auther, B. Cornblatt, C. S. Carter, R. Calkins, W. R. McFarlane, and +2 additional authors
American College of Rheumatology Criteria at Inception, and Accrual over 5 Years in the SLICC Inception Cohort, M. B. Urowitz, D. D. Gladman, D. Ibanez, J. Sanchez-Guerrero, J. Romero-Diaz, C. Gordon, S. C. Bae, A. E. Clarke, C. Aranow, T. Stoll, and +22 additional authors
High-mobility Group Box 1 Protein Initiates Postoperative Cognitive Decline by Engaging Bone Marrow-derived Macrophages, S. Vacas, V. Degos, K. J. Tracey, and M. Maze
Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables, D. Vancampfort, C. U. Correll, M. Wampers, P. Sienaert, A. J. Mitchell, A. De Herdt, M. Probst, T. W. Scheewe, and M. De Hert
Does a genetic variant in FOXO3A predict a milder course of rheumatoid arthritis?, H. W. van Steenbergen, S. Rantapaa-Dahlqvist, J. A. B. van Nies, E. Berglin, T. W. J. Huizinga, P. K. Gregersen, and A. H. M. van der Helm-van Mil
A 129-kb Deletion on Chromosome 12 Confers Substantial Protection Against Rheumatoid Arthritis, Implicating the Gene SLC2A3, C. D. Veal, K. E. Reekie, J. C. Lorentzen, P. K. Gregersen, L. Padyukov, and A. J. Brookes